Prostate News Archive
25-Sep-2008
Hormone Therapy Not Best for Older Prostate Cancer Patients (HealthDay via Yahoo! News)
TUESDAY, Sept. 23 (HealthDay News) -- Older men with early-stage prostate cancer who are given hormone therapy before radiation seed implant therapy face a 20 percent greater risk of dying than those who get radiation treatment alone, new research suggests. Study: Hormones not for all prostate cancer patients (USA Today)
A new study raises additional questions about the benefits of drugs given to more than half of prostate cancer patients. Prostate cancer hormone therapy may raise mortality (Reuters via Yahoo! News)
In elderly men with early-stage prostate cancer, receiving hormone therapy is associated with an increase in all-cause mortality, according to a study reported Tuesday at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting underway in Boston. For High-Risk Prostate Cancer Patients, New Tool Helps Physicians Tailor Hormone Therapy (Medical News Today)
Using one of the largest databases of prostate cancer outcomes in the United States, Fox Chase Cancer Center researchers have developed a prediction tool that uses a patient's clinical information to estimate the benefit of adding androgen deprivation therapy of various durations to radiation therapy. Who is more likely to get prostate cancer (Asheville Citizen-Times)
Who is at risk of developing prostate cancer? More than 65 percent of all prostate cancers are diagnosed in men over the age of 65. There is a twofold to elevenfold increase in developing prostate cancer when related to a first-degree male relative who also has developed prostate cancer.
Back to Prostate News Archive
